2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl
| 中文名称 | 2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl |
|---|---|
| 中文同义词 | TUNODAFIL;2-(2-乙氧基-5-((4-乙基哌嗪-1-基)磺酰基)苯基)-5-甲基-7-丙基-3,7-二氢-4H-吡咯并[2,3-D]嘧啶-4-酮;化合物 TUNODAFIL (FREE BASE) |
| 英文名称 | 2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl |
| 英文同义词 | 2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl;4H-Pyrrolo[2,3-d]pyrimidin-4-one, 2-[2-ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]phenyl]-3,7-dihydro-5-methyl-7-propyl-;tunodafilo;2-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one |
| CAS号 | 804518-63-6 |
| 分子式 | C24H33N5O4S |
| 分子量 | 487.61 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 804518-63-6.mol |
| 结构式 | ![]() |
2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl 性质
| 沸点 | 678.6±65.0 °C(Predicted) |
|---|---|
| 密度 | 1.32±0.1 g/cm3(Predicted) |
| 形态 | 固体 |
| 酸度系数(pKa) | 7.14±0.10(Predicted) |
| 颜色 | 米白色至浅黄色 |
| InChIKey | RXMDFMQMRASWOG-UHFFFAOYSA-N |
| SMILES | C1(C2=CC(S(N3CCN(CC)CC3)(=O)=O)=CC=C2OCC)NC(=O)C2C(C)=CN(CCC)C=2N=1 |
2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl 用途与合成方法
Yonkenafil (Tunodafil) 是一种新型磷酸二酯酶 5 (PDE5) 抑制剂,可有效减少脑梗塞、神经功能缺损、水肿和梗塞区域的神经元损伤。Yonkenafil 可能通过调节神经发生来改善认知功能,对阿尔茨海默病具有潜在的研究作用。
![2-[2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one 804519-64-0 HCl 804520-62-5 2HCl 结构式](CAS/20180808/GIF/804518-63-6.gif)